MARINUS PHARMACEUTICALS INC Business Finance Contracts & Agreements

Amendment No. 1 to the Equity Distribution Agreement, dated as of March 31, 2023, by and between Marinus Pharmaceuticals, Inc. and JMP Securities LLC (Filed With SEC on March 31, 2023)

Form of Pre-funded Warrant to Purchase Common Stock (Filed With SEC on November 10, 2022)

Underwriting Agreement, dated November 7, 2022, by and among Marinus Pharmaceuticals, Inc., SVB Securities LLC, RBC Capital Markets, LLC and Cantor Fitzgerald & Co (Filed With SEC on November 10, 2022)

Limited Consent and First Amendment to Credit Agreement, dated October 28, 2022, by and among Marinus Pharmaceuticals, Inc., as Grantor, and Oaktree Fund Administration, LLC, as... (Filed With SEC on November 7, 2022)

Security Agreement dated October 28, 2022, by and among Marinus Pharmaceuticals, Inc. and Sagard Healthcare Royalty Partners, LP (Filed With SEC on November 7, 2022)

Revenue Interest Financing Agreement, dated October 28, 2022, by and between Marinus Pharmaceuticals, Inc. and Sagard Healthcare Royalty Partners, LP (Filed With SEC on November 7, 2022)

Asset Purchase Agreement, dated July 13, 2022, by and between Marinus Pharmaceuticals, Inc. and Novo Nordisk Inc (Filed With SEC on July 14, 2022)

Form of Nonqualified Stock Option Agreement for Employees granted as an Inducement Award (Filed With SEC on November 9, 2021)

Underwriting Agreement, dated December 8, 2020, by and between Marinus Pharmaceuticals, Inc. and Cantor Fitzgerald & Co (Filed With SEC on December 9, 2020)

Underwriting Agreement, dated May 28, 2020, by and among Marinus Pharmaceuticals, Inc., Cowen and Company, LLC and Cantor Fitzgerald & Co (Filed With SEC on May 29, 2020)

Securities Purchase Agreement dated December 11, 2019 between the Company and the Investors listed therein (Filed With SEC on December 13, 2019)

Underwriting Agreement dated December 11, 2019 (Filed With SEC on December 13, 2019)

Underwriting Agreement, dated as of December 12, 2018, between the Company and Jefferies LLC and Leerink Partners LLC, as the Representatives of the several underwriters (Filed With SEC on December 14, 2018)

Equity Distribution Agreement dated as of October 31, 2017 between the Company and JMP Securities LLC (Filed With SEC on October 31, 2017)

Underwriting Agreement, dated as of September 15, 2017, between the Company and JMP Securities LLC, as the Representative of the several underwriters (Filed With SEC on September 15, 2017)

FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 2, 2016)

5,000,000 Shares Marinus Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on November 6, 2015)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on October 29, 2015)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on October 29, 2015)

NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on March 12, 2015)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 3, 2014)

[ ] Shares MARINUS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 18, 2014)

FORM OF MARINUS PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT , 2014 (Filed With SEC on July 9, 2014)

THIS DOCUMENT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. REDACTED MATERIAL IS... (Filed With SEC on May 12, 2014)

MARINUS PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT 1 (Filed With SEC on May 12, 2014)

ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on May 12, 2014)

THIS DOCUMENT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. REDACTED MATERIAL IS... (Filed With SEC on May 12, 2014)

MARINUS PHARMACEUTICALS, INC. FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on May 12, 2014)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 12, 2014)